In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents
- 1 February 2004
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 48 (2) , 101-105
- https://doi.org/10.1016/j.diagmicrobio.2003.09.009
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Role of Sentinel Surveillance of Candidemia: Trends in Species Distribution and Antifungal SusceptibilityJournal of Clinical Microbiology, 2002
- In Vitro Activities of Ravuconazole and Voriconazole Compared with Those of Four Approved Systemic Antifungal Agents against 6,970 Clinical Isolates of Candida sppAntimicrobial Agents and Chemotherapy, 2002
- International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and In Vitro Susceptibilities to Fluconazole, Ravuconazole, and Voriconazole of Isolates Collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance ProgramJournal of Clinical Microbiology, 2001
- In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: Review of the literatureMycopathologia, 2001
- In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.Journal of Antimicrobial Chemotherapy, 1999
- Evaluation of etest for determining in vitro susceptibility of yeast isolates to amphotericin BDiagnostic Microbiology and Infectious Disease, 1998
- In Vitro Activity of a New Oral Triazole, BMS-207147 (ER-30346)Antimicrobial Agents and Chemotherapy, 1998
- New and emerging yeast pathogensClinical Microbiology Reviews, 1995
- Fungemia and Colonization with Nystatin-Resistant Candida rugosa in a Burn UnitClinical Infectious Diseases, 1994
- Fatal Disseminated Candidiasis Due to Amphotericin-B-Resistant Candida guilliermondiiAnnals of Internal Medicine, 1985